News | Cardiovascular Business | March 15, 2024

Gilbert H. L. Tang Appointed Editor-in-Chief of JACC: Case Reports

Partnership targets heart failure, the leading cause of death and a condition with limited treatment options

Gilbert H. L. Tang, MD


March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case Reports, bringing a wealth of experience and expertise to the helm of one of the top cardiovascular journals published by the American College of Cardiology.

“I am both honored and humbled to be a cardiac surgeon among the Editor-in-Chiefs in the JACC family of journals,” Tang said. “It is going to be an exciting time for JACC: Case Reports to build on a team of multidisciplinary cardiovascular practitioners with diverse backgrounds and experiences, and at different stages of their professional careers, to enhance the journal’s academic and educational impact globally.”

Tang is currently serving as a professor in the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, the surgical director of the Structural Heart Program at the Mount Sinai Health System, and the director of Structural Heart Education at the Mount Sinai Fuster Heart Hospital in New York.

JACC: Case Reports is one of 10 journals in the ACC’s JACC platform of journals. It publishes high-quality, educationally valuable case reports, case series, images, and quality improvement projects covering all aspects of cardiology. It serves as a publication vehicle for early career cardiologists and members of the cardiovascular care team, providing a forum for mentorship on the review and publication process.

Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide. His research centers on the comprehensive management of patients post-TAVR, transcatheter mitral and tricuspid valve interventions, and advanced imaging techniques in structural heart disease.

In addition to serving on committees in the Heart Valve Collaboratory, and several clinical trials in structural heart, he has served as a member of the ACC Scientific Publications Committee. He is also a member of the ACC/STS TVT Research and Publications Committee, a four-time recipient of the JACC Simon Dack Award for Outstanding Scholarship and has served as an associate editor for Circulation: Cardiovascular Interventions.

Tang is a Diplomat and Fellow of the Royal College of Physicians and Surgeons of Canada (FRCSC), Fellow of the American College of Cardiology (FACC), and the first surgeon fellow of the Society for Cardiovascular Angiography and Interventions (SCAI). He has published over 250 peer-reviewed articles and lectures extensively worldwide.

“Together with members of our editorial board and through closer collaborations with international communities and the JACC family of journals, we will strive to make JACC: Case Reports the go-to digital resource to improve cardiovascular care and training worldwide,” Tang said.

As the new Editor-in-Chief, Tang will officially assume the role of Editor in Chief on August 1, 2024, with his first issue slated for August 7, 2024.

For more information: www.jacc.org


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now